These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Pro and con: Immunotherapy in acute leukemia. Arguments for immunotherapy]. Büchner T; Urbanitz D Internist (Berl); 1980 Jul; 21(7):362-6. PubMed ID: 7007269 [No Abstract] [Full Text] [Related]
8. [How to overcome the obstacles in the adoptive immunotherapy for leukemia]. Pan JX; Chen ZZ Zhonghua Nei Ke Za Zhi; 2008 Feb; 47(2):91-2. PubMed ID: 18683789 [No Abstract] [Full Text] [Related]
9. Adoptive cellular immunotherapy for childhood malignancies. Cooper LJ Bone Marrow Transplant; 2008 Jan; 41(2):183-92. PubMed ID: 18026145 [TBL] [Abstract][Full Text] [Related]
10. Expansion of antileukaemia CTL lines and clones for adoptive cell therapy in paediatric patients given allogeneic haematopoietic stem cell transplantation. Montagna D; Maccario R; Locatelli F Int J Immunogenet; 2008 Aug; 35(4-5):389-93. PubMed ID: 18976444 [TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy of leukemia]. Urbano-Ispizua A; Rozman C Med Clin (Barc); 1993 Mar; 100(12):454-6. PubMed ID: 8479218 [No Abstract] [Full Text] [Related]
13. [Immunological status change in leukemia patients with infectious complications and during immunotherapy]. Rozanova LM; Smirnova AI; Shcherbakova EG; Zinkovskaia LN; Eremina TN Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):18-20. PubMed ID: 7220515 [No Abstract] [Full Text] [Related]
14. Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation. Sangiolo D; Mesiano G; Carnevale-Schianca F; Piacibello W; Aglietta M; Cignetti A Expert Opin Biol Ther; 2009 Jul; 9(7):831-40. PubMed ID: 19463075 [TBL] [Abstract][Full Text] [Related]
15. [Active immunotherapy in the treatment of leukemias]. Mathé G Rev Prat; 1976 May; 26(29):2077-90. PubMed ID: 935773 [No Abstract] [Full Text] [Related]
16. [Application of gene therapy in tumor adoptive immunotherapy]. Wang C; Zhao Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):482-6. PubMed ID: 18610648 [TBL] [Abstract][Full Text] [Related]
17. Dendritic cell vaccines in acute leukaemia. Duncan C; Roddie H Best Pract Res Clin Haematol; 2008 Sep; 21(3):521-41. PubMed ID: 18790453 [TBL] [Abstract][Full Text] [Related]
18. Peptide vaccines for patients with acute myeloid leukemia. Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762 [TBL] [Abstract][Full Text] [Related]
19. Tracking the elusive lymphocyte: methods of detection during adoptive immunotherapy. Skitzki JJ; Muhitch JB; Evans SS Immunol Invest; 2007; 36(5-6):807-27. PubMed ID: 18161530 [TBL] [Abstract][Full Text] [Related]
20. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy. Rolle CE; Carrio R; Malek TR Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]